Press release
The Peptic Ulcer Drugs Market to simulate the digitized way, reaching US$ 47.7 Bn between 2020-2030
The Peptic Ulcer Drugs Market is all set to create greater strides for the Peptic Ulcer Drugs Market in the upcoming period. Big data analytics is flowing through the veins of the healthcare vertical these days. This practice helps in providing better insights to healthcare practitioners. The healthcare vertical has started depending on analytics' expertise for deciphering data collected through various sources and monitoring processes' efficiency.Surge in the consumption of NSAIDs due to growing prevalence of inflammatory diseases is the major factor driving the growth of the global peptic ulcer drugs market. Other trends driving growth include increasing adoption of peptic ulcer drugs over surgery, changes in disease management, prevalence of stress ulcers due to higher smoking rates, availability of affordable therapy due to improvements in the service sector, and increasing awareness toward disease management through government campaigns. However, chronic side-effects associated with the long-term use of peptic ulcer drugs is a factor hampering the growth of the global peptic ulcer drugs market to some extent.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3704
As per PMR analysis, the global peptic ulcer drugs market is set for steady growth over the next ten years, to be valued at US$ 47.7 Bn by 2030-end.
Company Profiles:
Pfizer Inc.
Abbvie Inc.
GlaxoSmithKline plc.
AstraZeneca plc
Boehringer Ingelheim GmbH
Daewoong Pharmaceutical Co., Ltd.
Takeda Pharmaceutical
Eisai Co. Ltd.
Cadila Healthcare Ltd.
Yuhan Corporation
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3704
Key Takeaways from Peptic Ulcer Drugs Market Study
By product, the proton pump inhibitors segment was the largest revenue generating segment in the historical years. However, revenue from the potassium-competitive acid blockers segment is expected to expand rapidly, owing to the introduction of new P-CAB drugs in the market.
Based on indication, the gastric ulcers segment is anticipated to expand at the highest CAGR of 3% over the forecast period.
On the basis of distribution channel, the hospital pharmacies segment led the global peptic ulcer drugs market, and is expected to remain the leading segment ahead too. Increasing hospitalization rates due to ulcer complications are expected to be the primary factor fuelling revenue growth of the segment over the forecast period.
North America holds the largest share in the global peptic ulcer drugs market, followed by Europe and East Asia.
Due to the worldwide COVID-19 outbreak, physician and hospital visits for non-essential treatment have reduced considerably, putting breaks on the progress of the peptic ulcer drugs market space.
"Increasing NSAID consumption is the major boosting factor for the growth of the global peptic ulcer drugs market," says a PMR analyst.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3704
Peptic Ulcer Drugs Market: Competition Analysis
Key players operating in the global peptic ulcer drugs market are Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Pharmaceuticals Ltd. These companies are primarily focusing on strategies such as co-promotions and co-marketing of their brands to penetrate the fastest-growing emerging markets across the world.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/peptic-ulcer-drugs-market.asp
What Else is in the Report?
Persistence Market Research offers a unique perspective and actionable insights on the peptic ulcer drugs market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030. Research of this report has been done based segmentation into product, indication, and distribution channel, across seven key regions of the world.
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Peptic Ulcer Drugs Market to simulate the digitized way, reaching US$ 47.7 Bn between 2020-2030 here
News-ID: 2595033 • Views: …
More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market
The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,…

Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market
The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert…

Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market
The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across…

Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that…
More Releases for Peptic
Peptic Ulcer Market New Product Development & Latest Trends
Introduction
Peptic ulcers are open sores that develop on the inner lining of the stomach and the upper portion of the small intestine. They are primarily caused by Helicobacter pylori (H. pylori) infection, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking, alcohol consumption, and stress-related factors. Symptoms include abdominal pain, bloating, indigestion, and, in severe cases, gastrointestinal bleeding or perforation.
Despite improved therapeutic options, peptic ulcers remain a major healthcare concern worldwide…
Evolving Market Trends In The Peptic Ulcer Industry: Advancements In Peptic Ulce …
The Peptic Ulcer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Peptic Ulcer Market Size During the Forecast Period?
In recent times, there has been a consistent expansion in the peptic ulcer market size. It is projected to escalate from $4.1 billion…
Key Influencer in the Peptic Ulcer Market 2025: Obesity Fuels The Expansion Of T …
What Is the Forecasted Market Size and Growth Rate for the Peptic Ulcer Market?
The peptic ulcer market has grown steadily in recent years. It will rise from $4.1 billion in 2024 to $4.24 billion in 2025, at a CAGR of 3.5%. This growth is attributed to the rising prevalence of Helicobacter pylori infection, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns, and a focus…
Peptic Ulcer Drugs Market - Relief Within Reach: Transforming Treatment for Pept …
Newark, New Castle, USA - new report, titled Peptic Ulcer Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peptic Ulcer Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peptic Ulcer Drugs market. The report offers an overview of…
Peptic Ulcer Market Shares, Strategies, and Forecasts Analysis
Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance. These can be of three types: gastric ulcers, duodenal ulcers, and esophageal ulcers. Some of the causes of peptic ulcers are stomach infections caused by H. pylori, alcoholism, stomach cancers, usage of anti-inflammatory drugs such as aspirin, and smoking. Peptic ulcers, if…
Anti-Peptic Ulcer Drugs Market Development in 2019
Global Anti-Peptic Ulcer Drugs Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2019 to 2025.
The report of global Anti-Peptic Ulcer Drugs market includes the competitive landscape section…